<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Atrial tachyarrhythmias in children</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Atrial tachyarrhythmias in children</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Atrial tachyarrhythmias in children</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Ronald J Kanter, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John K Triedman, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Carrie Armsby, MD, MPH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 30, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H5913098"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Atrial tachyarrhythmias (ATs) are non-sinus arrhythmias that result in a heart rate above the 95<sup>th</sup> percentile for age and that do not require the atrioventricular (AV) junction, accessory pathways, or ventricular tissue for initiation and maintenance of the elevated heart rate.</p><p>In pediatric patients, ATs are most commonly seen in children with structural congenital heart disease (CHD) who have undergone cardiac surgery; they can also occur in children without CHD and may result in significant morbidity.</p><p>Related topics include:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/13599.html" rel="external">"Atrial arrhythmias (including AV block) in congenital heart disease"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/6765.html" rel="external">"Fetal arrhythmias"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/5783.html" rel="external">"Clinical features and diagnosis of supraventricular tachycardia (SVT) in children"</a> and  <a class="medical medical_review" href="/z/d/html/5782.html" rel="external">"Management of supraventricular tachycardia (SVT) in children"</a>.)</p><p></p><p class="headingAnchor" id="H5913105"><span class="h1">TERMINOLOGY</span><span class="headingEndMark"> — </span>AT is a subset of supraventricular tachycardia (SVT). SVT is a broad group of tachycardic disorders that includes any non-sinus rapid rhythm that arises from structures above the bundle branches, including the atrium  (<a class="graphic graphic_table graphicRef131338" href="/z/d/graphic/131338.html" rel="external">table 1</a>).</p><p>ATs can be classified based on the P wave phenotype on electrocardiogram (ECG), whether a single or multiple foci are involved in the origin of the tachycardia, and the frequency and duration of tachycardia (ie, sporadic/paroxysmal, frequently recurrent, or persistent tachycardia). The tachyarrhythmia mechanism (macroreentry, microreentry, enhanced automaticity, and triggered) only loosely correlates with this schema and should be avoided as part of the classification nomenclature unless the mechanism is clearly known. For completeness sake, atrial flutter and fibrillation are also discussed in this review.</p><p>The following classification is used in this review:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Primary atrial tachycardia</strong> – The term "primary atrial tachycardia" implies a non-sinus tachycardia with discrete and monotonous P waves. Beyond this general term, the nomenclature continues to evolve. Focal atrial tachycardias (FAT; also referred to as atrial ectopic tachycardia [AET] or ectopic atrial tachycardia [EAT]) arise from a single site within the left or right atrium. FAT can be automatic or nonautomatic (see  <a class="medical medical_review" href="/z/d/html/900.html" rel="external">"Focal atrial tachycardia"</a>): </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Automatic FAT </strong>emanates from a single atrial focus, is mostly incessant, and has a variable rate over time that is influenced by the autonomic nervous system. Progressive rate acceleration over the first several beats is frequently observed. During periods of marked vagotonia, automatic FAT may be suppressed in some individuals. The P waves are discrete and non-sinus in appearance. As with all pathologic ATs, the PR interval may be inappropriately long relative to the atrial rate. This tachycardia occurs due to an area of enhanced automaticity.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Nonautomatic FAT </strong>also due to a single focus, behaves in a paroxysmal manner, stopping and starting abruptly  (<a class="graphic graphic_waveform graphicRef74611" href="/z/d/graphic/74611.html" rel="external">waveform 1A</a>). It may be a rare sporadic event or may recur frequently, even nearly incessantly. The rate is usually relatively constant within a given paroxysm. Microreentry or triggered activity are thought to be the most common mechanisms. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Sinoatrial node reentry tachycardia (SANRT)</strong> is a form of nonautomatic FAT that is sometimes categorized separately. Like all reentry tachycardias, it starts and stops abruptly  (<a class="graphic graphic_waveform graphicRef131133 graphicRef131339" href="/z/d/graphic/131133.html" rel="external">waveform 2A-B</a>). Its P waves are identical to sinus P waves as it emanates from the head of the sinoatrial node. Similar to FAT, the PR interval may be longer than expected for the tachycardia rate. It may be terminated with intravenous <a class="drug drug_pediatric" data-topicid="13258" href="/z/d/drug information/13258.html" rel="external">adenosine</a>. (See  <a class="medical medical_review" href="/z/d/html/918.html" rel="external">"Sinoatrial nodal reentrant tachycardia (SANRT)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Chaotic atrial tachycardia (CAT)</strong> – CAT (called multifocal atrial tachycardia in adults) is diagnosed when there are at least three different rapidly depolarizing, non-sinus P wave morphologies during a 10-second rhythm strip or ECG  (<a class="graphic graphic_waveform graphicRef52317" href="/z/d/graphic/52317.html" rel="external">waveform 3</a>). Classically defined, there should be irregular P-P, P-R, and R-R intervals. The degree of persistence versus intermittency of the tachycardia is not implied by the name. (See  <a class="medical medical_review" href="/z/d/html/901.html" rel="external">"Multifocal atrial tachycardia"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Atrial fibrillation</strong> – Atrial fibrillation involves multiple, simultaneous atrial reentry wavelets that appear on a rhythm strip as a low-amplitude or choppy, irregular baseline with a variable R-R interval  (<a class="graphic graphic_waveform graphicRef62698" href="/z/d/graphic/62698.html" rel="external">waveform 4</a>). (See  <a class="medical medical_review" href="/z/d/html/1022.html" rel="external">"Atrial fibrillation: Overview and management of new-onset atrial fibrillation"</a> and  <a class="medical medical_review" href="/z/d/html/1004.html" rel="external">"Epidemiology, risk factors, and prevention of atrial fibrillation"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Atrial flutter</strong> – Atrial flutter is a macroreentry tachycardia in which the critical part of the large electrical circuit passes between the inferior vena cava and the tricuspid valve annulus, the cavotricuspid isthmus. It manifests as a sawtooth pattern on ECG, usually with 2:1 atrioventricular (AV) conduction  (<a class="graphic graphic_waveform graphicRef82303 graphicRef72312" href="/z/d/graphic/82303.html" rel="external">waveform 5A-B</a>). There are two forms of atrial flutter: "counterclockwise" atrial flutter, which has a negative sawtooth pattern in leads II, II, and aVF, and "clockwise" atrial flutter, which has a positive sawtooth pattern in these leads. The pattern is often better observed when an intravenous bolus of <a class="drug drug_pediatric" data-topicid="13258" href="/z/d/drug information/13258.html" rel="external">adenosine</a> is administered. In the absence of structural heart disease, pediatric atrial flutter most commonly occurs in the fetus and newborn. (See  <a class="medical medical_review" href="/z/d/html/1048.html" rel="external">"Overview of atrial flutter"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Intraatrial reentrant tachycardia (IART)</strong> – IART, sometimes referred to as "atypical atrial flutter" or "incisional atrial tachycardia," implies a macroreentry mechanism and usually follows surgery for congenital heart disease (CHD). Its appearance and behavior are akin to atrial flutter, although, by definition, the anatomical substrate of IART is different than that of typical atrial flutter. (See  <a class="medical medical_review" href="/z/d/html/13599.html" rel="external">"Atrial arrhythmias (including AV block) in congenital heart disease", section on 'Intraatrial reentrant tachycardia'</a>.)</p><p></p><p>Descriptors of AT, such as "sporadic," "frequently recurrent," "nonsustained incessant," and "persistent," help communicate the tachycardia behavior but may also lead to confusion. These terms represent a continuum that describes the frequency and persistence of the arrhythmia, but the mechanism is not implied.</p><p>In some conditions, the above classification implies the underlying tachyarrhythmia mechanism (SANRT, IART, atrial flutter, atrial fibrillation) but not in others (FAT, CAT). Although the correlation of mechanism with rhythm strip phenotype is imperfect, there are some clinical features that are associated with specific mechanisms. (See  <a class="medical medical_review" href="/z/d/html/943.html" rel="external">"Narrow QRS complex tachycardias: Clinical manifestations, diagnosis, and evaluation", section on 'Automaticity and triggered activity'</a> and  <a class="medical medical_review" href="/z/d/html/943.html" rel="external">"Narrow QRS complex tachycardias: Clinical manifestations, diagnosis, and evaluation", section on 'Mechanisms of reentry'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>Reentry always implies a sudden onset and termination of tachycardia. For single anatomic circuit reentrant mechanisms (eg, SANRT, IART, atrial flutter), the atrial rate is constant within an episode.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Enhanced automaticity occurs when a small area of atrial muscle has depolarization properties that are faster than those of the underlying or normal atrial tissue and sinoatrial node. Such a site tends to depolarize at rates that vary over time and are influenced by changes in autonomic tone.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Triggered activity occurs when a site suddenly and rapidly depolarizes in response to catecholamine surge and secondary intracellular calcium loading. The rate is also relatively constant within a given episode. This mechanism may be very difficult to prove.</p><p></p><p>The other important distinction that defines the classification of pediatric ATs is whether or not the child has undergone cardiac surgery. Atrial arrhythmias associated with CHD and cardiac surgery are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/13599.html" rel="external">"Atrial arrhythmias (including AV block) in congenital heart disease"</a>.)</p><p>Our approach is to use the above classification schema delineated by the rhythm strip, adding modifiers based upon the onset, frequency, and/or persistence of tachycardia episodes and, if known, the underlying mechanism (eg, sporadic nonautomatic FAT, nonsustained incessant CAT, or persistent automatic FAT).</p><p class="headingAnchor" id="H5913112"><span class="h1">EPIDEMIOLOGY</span></p><p class="headingAnchor" id="H332962505"><span class="h2">Prevalence</span><span class="headingEndMark"> — </span>In children and infants without cardiac surgery, primary atrial tachycardia appears throughout infancy and childhood and accounts for 14 percent of supraventricular tachycardia (SVT) cases [<a href="#rid1">1</a>]. Since SVT occurs in approximately 1 in 200 to 400 children, the estimated prevalence of primary atrial tachycardia in children is approximately 1 in 1500 to 3000 children. By comparison, the prevalence of focal atrial tachycardia (FAT) in healthy adults in one report was 1 in 300 [<a href="#rid2">2</a>]. (See  <a class="medical medical_review" href="/z/d/html/5783.html" rel="external">"Clinical features and diagnosis of supraventricular tachycardia (SVT) in children", section on 'Epidemiology'</a>.)</p><p class="headingAnchor" id="H1755010314"><span class="h2">Associated conditions</span></p><p class="headingAnchor" id="H3291066746"><span class="h3">Congenital heart disease</span><span class="headingEndMark"> — </span>The prevalence of ATs in patients with congenital heart disease (CHD) is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/13599.html" rel="external">"Atrial arrhythmias (including AV block) in congenital heart disease", section on 'Prevalence and incidence'</a>.)</p><p class="headingAnchor" id="H3290143988"><span class="h3">Cardiac tumors</span><span class="headingEndMark"> — </span>Nearly any kind of cardiac tumor arising from or invading the atrial wall or annulus fibrosis can predispose to a variety of tachycardias, including ATs. Cardiac tumors most commonly seen in children are rhabdomyomas, fibromas, lymphoma, and myxomas. Their presence may be an important indicator of an underlying serious condition, especially tuberous sclerosis in the case of rhabdomyomas. (See  <a class="medical medical_review" href="/z/d/html/6175.html" rel="external">"Tuberous sclerosis complex: Clinical features"</a>.)</p><p class="headingAnchor" id="H3843944550"><span class="h3">Channelopathies</span><span class="headingEndMark"> — </span>It is increasingly recognized that ATs also may occur in patients with heritable primary arrhythmia syndromes, including long and short QT syndrome, Brugada syndrome, and catecholaminergic polymorphic ventricular tachycardia. Up to 30 percent of patients with these conditions experience ATs [<a href="#rid3">3</a>]. Certain variants in the sodium channel gene, <em>SCN5A</em>, have shown a particular predilection to cause ATs, often with other dangerous arrhythmias [<a href="#rid4">4</a>]. Thus, the presence of ATs that are not otherwise explained should prompt consideration of these syndromes. (See  <a class="medical medical_review" href="/z/d/html/1036.html" rel="external">"Congenital long QT syndrome: Epidemiology and clinical manifestations"</a> and  <a class="medical medical_review" href="/z/d/html/106759.html" rel="external">"Brugada syndrome: Clinical presentation, diagnosis, and evaluation"</a> and  <a class="medical medical_review" href="/z/d/html/916.html" rel="external">"Catecholaminergic polymorphic ventricular tachycardia"</a>.)</p><p class="headingAnchor" id="H13036866"><span class="h3">Neuromuscular disease</span><span class="headingEndMark"> — </span>ATs are relatively common in individuals with neuromuscular diseases, especially Duchenne muscular dystrophy, Friedreich ataxia, some forms of Emery-Dreifuss and limb-girdle muscular dystrophy, and myotonic dystrophy type I [<a href="#rid5">5</a>]. In Duchenne muscular dystrophy, ATs are associated with diminished ejection fraction [<a href="#rid6">6</a>]. (See  <a class="medical medical_review" href="/z/d/html/6149.html" rel="external">"Duchenne and Becker muscular dystrophy: Clinical features and diagnosis", section on 'Cardiomyopathy'</a> and  <a class="medical medical_review" href="/z/d/html/6224.html" rel="external">"Friedreich ataxia", section on 'Cardiomyopathy'</a>.)</p><p class="headingAnchor" id="H1032999183"><span class="h3">Other genetic disorders</span><span class="headingEndMark"> — </span>ATs occur more frequently than expected in certain genetic conditions (eg, Noonan syndrome, Costello syndrome [and other RASopathies], and William syndrome), even in the absence of apparent structural heart disease [<a href="#rid7">7</a>]. </p><p class="headingAnchor" id="H5913135"><span class="h1">CLINICAL FEATURES</span></p><p class="headingAnchor" id="H5913143"><span class="h2">Presenting symptoms</span><span class="headingEndMark"> — </span>Signs and symptoms of ATs depend upon the duration and persistence of the tachycardia and the rate of ventricular response. The patient's age also impacts the presentation. Infants and toddlers cannot verbally describe symptoms and may present after a more prolonged duration of arrhythmia and, therefore, with more serious findings. Older children who can describe palpitations are generally detected earlier.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Paroxysmal (sporadic) tachycardia</strong> – Sporadic nonautomatic focal atrial tachycardia (FAT) and atrial flutter are the most common ATs in this clinical category. The presentation of these paroxysmal ATs is similar to that of more common forms of supraventricular tachycardia (SVT; ie, atrioventricular [AV] reciprocating tachycardia and AV node reentrant tachycardia). They typically present with sudden palpitations, shortness of breath, presyncope, dizziness, and, sometimes, chest pain. Preverbal children may become irritable or suddenly quiet with associated pallor, diaphoresis, and feeding intolerance. In one report, ATs were more likely to present with fatigue and less likely with palpitations, dyspnea, or dizziness compared with other forms of SVT [<a href="#rid8">8</a>].</p><p></p><p class="bulletIndent1">In some patients with rapid atrial flutter, these symptoms may initially be lacking if there is 2:1 AV conduction. In these patients, atrial flutter may become persistent and, if untreated, it can lead to tachycardia-induced cardiomyopathy (ie, the ventricular rate is slow enough that acute symptoms do not occur but fast enough to eventually impair ventricular function). Sporadic symptoms in such patients may represent moments of 1:1 AV conduction but within the context of a persistent arrhythmia.</p><p></p><p class="bulletIndent1">Syncope is a relatively uncommon sign of AT, and it may be associated with increased risk of sudden death, especially in children who have undergone cardiac surgery.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sustained tachycardia</strong> – As a group, sustained ATs ("persistent" or "nonsustained incessant," using the nomenclature above) are more likely to represent automatic FAT, incessant or frequently recurring nonautomatic FAT, and, in infants, chaotic atrial tachycardia (CAT). They usually are associated with a slower ventricular rate than the more common types of SVT (ie, AV reciprocating tachycardia and AV node reentrant tachycardia) and other types of AT (eg, sporadic nonautomatic FAT).</p><p></p><p class="bulletIndent1">Affected patients may not recognize palpitations or may be unable to verbalize symptoms and may only come to medical attention after the development of heart failure. This is called tachycardia-induced cardiomyopathy. FAT is the most common cause of tachycardia-induced cardiomyopathy, accounting for approximately 60 percent of cases [<a href="#rid9">9</a>]. Affected patients have left ventricular (LV) dilatation and impaired LV function [<a href="#rid10">10</a>]. The atrial rate at which this is likely to develop is not well defined. In our experience, adolescents seem to tolerate average heart rates of 110 to 120 beats per minute (bpm) with normal cardiac function for up to eight years.</p><p></p><p class="bulletIndent1">Clinical manifestations of tachycardia-induced cardiomyopathy vary depending upon the patient's age:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Infants present with nonspecific signs of heart failure including tachypnea, poor feeding, sweating, and failure to thrive. These symptoms are more common when the infants increase their exertion, such as during feeding.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Older children and teenagers present with complaints of palpitations and/or classic symptoms of heart failure including dyspnea, fatigue with an inability to keep up with peers, respiratory distress, and diaphoresis (sweating). Symptoms are more severe and common with exertion.</p><p></p><p class="bulletIndent1">Clinical improvement is expected to occur after ablation therapy for FAT [<a href="#rid11">11</a>], with normalization of LV contractility and, later, reduction in LV volume within 7 to 10 weeks of the procedure [<a href="#rid9">9</a>]. However, patients may have persistent derangement in diastolic function and cardiac interstitial fibrosis, thought to represent permanent damage, has been reported one year after resolution of the tachycardia [<a href="#rid12">12</a>].</p><p></p><p class="headingAnchor" id="H5913166"><span class="h2">Clinical features of specific atrial tachyarrhythmias</span></p><p class="headingAnchor" id="H5913174"><span class="h3">Focal atrial tachycardia</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Presentation</strong> – In children, the presentation of FAT can range from sporadic episodes (more likely nonautomatic FAT) of mild symptoms of palpitations and dizziness to sustained tachycardia with heart failure from tachycardia-induced cardiomyopathy (more likely automatic FAT) [<a href="#rid10">10</a>]. They can occur at any age and are most commonly of idiopathic origin. </p><p></p><p class="bulletIndent1">Patients with congenital heart disease (CHD) are at increased risk of developing FAT, particularly following surgical repair. In one study, FAT occurred postoperatively in 2.5 percent of all CHD surgeries in infants &lt;1 year old [<a href="#rid13">13</a>]. (See  <a class="medical medical_review" href="/z/d/html/13599.html" rel="external">"Atrial arrhythmias (including AV block) in congenital heart disease", section on 'Ectopic/focal atrial tachycardia'</a>.) </p><p></p><p class="bulletIndent1">FAT has also been reported in association with cardiomyopathy, myocarditis, myocardial infarction, respiratory infection, chronic pulmonary disease (eg, bronchopulmonary dysplasia, pulmonary hypertension), and lung transplantation [<a href="#rid14">14-16</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Anatomic substrate</strong> – In children without CHD, the anatomic substrate for nonautomatic FAT is most commonly along the crista terminalis of the right atrium, the ostium of the coronary sinus, the tricuspid or mitral valve annuli, or the atrial appendages. There are several reports of FAT associated with right atrial appendage aneurysms [<a href="#rid17">17-19</a>]. However, FAT can arise from virtually anywhere in the atrial mass, including the atrial septum [<a href="#rid20">20,21</a>], the noncoronary cusp of the aortic valve [<a href="#rid22">22</a>], and the muscular sleeves of the proximal superior and inferior vena cavae and pulmonary veins. FAT may also arise from atrial tumors, notoriously from rhabdomyomas. (See  <a class="medical medical_review" href="/z/d/html/4881.html" rel="external">"Cardiac tumors"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Electrocardiogram (ECG) findings</strong> – ECG findings are described below. (See <a class="local">'Electrocardiogram findings'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Natural history</strong> – Affected infants and young children are generally responsive to medical therapy, and there is a reasonable likelihood of spontaneous resolution after a few months or years [<a href="#rid23">23,24</a>]. In one report of infants &lt;6 months of age, the arrhythmia spontaneously resolved within one year in 14 of 15 patients (93 percent) [<a href="#rid23">23</a>]. In contrast, older children (&gt;3 years of age) are less likely to respond to medical therapy and have a lower resolution rate. In several case series, spontaneous remission rates vary from 34 to 75 percent for patients up to 18 years of age within 10 to 28 months of diagnosis [<a href="#rid14">14,24-27</a>]. (See  <a class="medical medical_review" href="/z/d/html/900.html" rel="external">"Focal atrial tachycardia"</a>.)</p><p></p><p class="headingAnchor" id="H5913182"><span class="h3">Chaotic atrial tachycardia</span><span class="headingEndMark"> — </span>CAT (also referred to as multifocal atrial tachycardia in adults) is an uncommon arrhythmia in children. (See  <a class="medical medical_review" href="/z/d/html/901.html" rel="external">"Multifocal atrial tachycardia"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Presentation</strong> – It usually occurs as a transient disorder during early infancy with mild ventricular dysfunction, often associated with a respiratory illness [<a href="#rid28">28</a>]. CAT can also occur in patients with structural heart disease and in infants with the RASopathies (especially Costello and Noonan syndromes) with or without underlying ventricular hypertrophy [<a href="#rid29">29-31</a>]. (See  <a class="medical medical_review" href="/z/d/html/13558.html" rel="external">"Noonan syndrome"</a> and  <a class="medical medical_review" href="/z/d/html/4951.html" rel="external">"Hypertrophic cardiomyopathy in children: Clinical manifestations and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Anatomic substrate</strong> – Anecdotal reports suggest that this arrhythmia emanates from multiple pulmonary veins, similar to the origin of atrial fibrillation in adults [<a href="#rid32">32</a>]. However, in some cases, CAT may emanate from a single ectopic focus [<a href="#rid33">33</a>]. The mechanisms of CAT are poorly understood, and it likely involves multiple mechanisms.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>ECG findings</strong> – ECG findings are described below. (See <a class="local">'Electrocardiogram findings'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Natural history</strong> – When CAT occurs in infancy, it typically resolves completely after six months [<a href="#rid15">15,34-37</a>]. Late arrhythmias are unlikely to occur, and the prognosis for long-term outcome is excellent in children with no underlying abnormality. If this rhythm persists or recurs late, there is evidence that it may be a manifestation of an underlying channelopathy, especially catecholaminergic polymorphic ventricular tachycardia, a heritable channelopathy caused by mutations in the <em>RYR2</em> gene [<a href="#rid28">28</a>]. (See  <a class="medical medical_review" href="/z/d/html/916.html" rel="external">"Catecholaminergic polymorphic ventricular tachycardia"</a>.)</p><p></p><p class="bulletIndent1">When associated with structural heart disease, the outcome is dependent upon the underlying condition. When associated with Costello and Noonan syndrome, CATs may have a malignant course and can be difficult to treat [<a href="#rid28">28</a>]. (See  <a class="medical medical_review" href="/z/d/html/13558.html" rel="external">"Noonan syndrome", section on 'Prognosis'</a> and  <a class="medical medical_review" href="/z/d/html/110392.html" rel="external">"Hypertrophic cardiomyopathy in children: Management and prognosis", section on 'Prognosis'</a>.)</p><p></p><p class="headingAnchor" id="H1314527094"><span class="h3">Atrial fibrillation</span><span class="headingEndMark"> — </span>Atrial fibrillation is uncommon in children. It can occur in the following settings [<a href="#rid38">38,39</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Patients with underlying cardiac disease, including:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Structural CHD (see  <a class="medical medical_review" href="/z/d/html/13599.html" rel="external">"Atrial arrhythmias (including AV block) in congenital heart disease", section on 'Atrial fibrillation'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Cardiomyopathies, especially hypertrophic cardiomyopathy [<a href="#rid40">40</a>] (see  <a class="medical medical_review" href="/z/d/html/4951.html" rel="external">"Hypertrophic cardiomyopathy in children: Clinical manifestations and diagnosis"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Wolff-Parkinson-White syndrome (see  <a class="medical medical_review" href="/z/d/html/962.html" rel="external">"Wolff-Parkinson-White syndrome: Anatomy, epidemiology, clinical manifestations, and diagnosis", section on 'Atrial fibrillation'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Channelopathies – Some channelopathies, previously thought to only potentiate sudden cardiac death from ventricular tachyarrhythmias (eg, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia), may also manifest with atrial fibrillation [<a href="#rid40">40,41</a>] (see  <a class="medical medical_review" href="/z/d/html/106759.html" rel="external">"Brugada syndrome: Clinical presentation, diagnosis, and evaluation"</a> and  <a class="medical medical_review" href="/z/d/html/916.html" rel="external">"Catecholaminergic polymorphic ventricular tachycardia"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Following a triggering event – Paroxysmal atrial fibrillation may occur in a biologically predisposed but otherwise completely healthy individual during a hypervagal event or after drinking a cold or alcoholic beverage.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Following an episode of a more common form of SVT – There is a growing appreciation of adolescent patients who develop atrial fibrillation immediately following a more common SVT, so-called "tachycardia-induced-tachycardia" [<a href="#rid42">42</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hyperthyroidism – In rare cases, atrial fibrillation may be seen in a child with hyperthyroidism; however, in this setting, assessment should include an evaluation for a possible structural heart lesion. (See  <a class="medical medical_review" href="/z/d/html/5841.html" rel="external">"Clinical manifestations and diagnosis of Graves disease in children and adolescents"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Familial cases – There have been reported rare familial cases of atrial fibrillation; both autosomal dominant and recessive forms have been identified. This is discussed in greater detail separately. (See  <a class="medical medical_review" href="/z/d/html/1004.html" rel="external">"Epidemiology, risk factors, and prevention of atrial fibrillation", section on 'Monogenic inheritance'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Athletes – Atrial fibrillation can sometimes be observed in the hyper-conditioned adolescent athlete. (See  <a class="medical medical_review" href="/z/d/html/991.html" rel="external">"Athletes with arrhythmias: Electrocardiographic abnormalities and conduction disturbances", section on 'Atrial fibrillation and atrial flutter'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Idiopathic atrial fibrillation in the young – It is increasingly recognized that atrial fibrillation can rarely occur in otherwise healthy adolescents and young adults in the absence of structural heart disease, prior surgery, cardiomyopathy, ventricular pre-excitation, family history, or other risk factors (hypertension, thyroid disease). This has sometimes been called "lone atrial fibrillation" [<a href="#rid43">43</a>]. </p><p></p><p>The ECG findings for atrial fibrillation are briefly summarized below (see <a class="local">'Electrocardiogram findings'</a> below) and are described in detail separately. (See  <a class="medical medical_review" href="/z/d/html/1014.html" rel="external">"The electrocardiogram in atrial fibrillation"</a>.)</p><p class="headingAnchor" id="H5913190"><span class="h3">Atrial flutter and intraatrial reentry tachycardia</span><span class="headingEndMark"> — </span>Atrial flutter is rare in children. It can occur in the following settings:</p><p class="bulletIndent1"><span class="glyph">●</span>Atrial flutter and intraatrial reentrant tachycardia (IART) following cardiac surgery – Atrial flutter and IART are primarily seen in children with a history of previous cardiac surgery, particularly following the Mustard, Senning, or Fontan procedures [<a href="#rid44">44-47</a>]. (See  <a class="medical medical_review" href="/z/d/html/13599.html" rel="external">"Atrial arrhythmias (including AV block) in congenital heart disease"</a> and  <a class="medical medical_review" href="/z/d/html/15851.html" rel="external">"D-transposition of the great arteries (D-TGA): Management and outcome", section on 'Arrhythmias'</a> and  <a class="medical medical_review" href="/z/d/html/95232.html" rel="external">"Management of complications in patients with Fontan circulation", section on 'Arrhythmias'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Neonatal atrial flutter – Atrial flutter can occur in fetuses and neonates with structurally normal hearts. This usually occurs in an otherwise uncomplicated pregnancy; however, cases of atrial flutter associated with maternal <a class="drug drug_pediatric" data-topicid="12559" href="/z/d/drug information/12559.html" rel="external">lithium</a> treatment [<a href="#rid48">48</a>] and neonatal Coxsackie myocarditis [<a href="#rid49">49</a>] have been described. The mechanism for atrial flutter in this setting is thought to be similar to adults, involving macroreentry around the tricuspid valve, although definitive studies have not been performed. Neonatal atrial flutter rarely recurs following cardioversion with or without medical treatment.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Atrial flutter in children with structurally normal hearts – Atrial flutter is exceedingly rare in older children with structurally normal hearts. Similar to atrial fibrillation, some patients may develop atrial flutter immediately following a more common SVT. Thus, a child without structural heart disease who presents with atrial flutter should be evaluated for more common forms of SVT (ie, AV reentrant tachycardia and AV nodal reentrant tachycardia) or subclinical channelopathic, neuromuscular, or other genetic disorders. (See  <a class="medical medical_review" href="/z/d/html/5783.html" rel="external">"Clinical features and diagnosis of supraventricular tachycardia (SVT) in children"</a>.)</p><p></p><p>The ECG findings for atrial flutter and intraatrial re-entry tachycardia are briefly summarized below (see <a class="local">'Electrocardiogram findings'</a> below) and are described in detail separately. (See  <a class="medical medical_review" href="/z/d/html/1061.html" rel="external">"Electrocardiographic and electrophysiologic features of atrial flutter"</a>.)</p><p class="headingAnchor" id="H247389409"><span class="h2">Electrocardiogram findings</span><span class="headingEndMark"> — </span>In all ATs, the ECG demonstrates an inappropriately rapid heart rate for age (ie, above the 95<sup>th</sup> percentile) and narrow QRS complex.</p><p>Specific ECG characteristics are as follows:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>FAT</strong> – The QRS complexes appear normal and occur at regular intervals (other than possible "warmup" at the onset of some FATs). The P wave has a uniform morphology, but its appearance usually differs from sinus rhythm and is dependent on the location of the focus  (<a class="graphic graphic_waveform graphicRef74611" href="/z/d/graphic/74611.html" rel="external">waveform 1A</a>). The relationship of the P wave with the next QRS tends to be constant, unless there is second-degree AV block  (<a class="graphic graphic_waveform graphicRef59685" href="/z/d/graphic/59685.html" rel="external">waveform 1B</a>). Although the P-R interval is inappropriately long relative to the atrial rate, the P-R interval does tend to be shorter than the ensuing R-P interval. The P wave may be difficult to discriminate if it is buried in the prior T wave. (See  <a class="medical medical_review" href="/z/d/html/900.html" rel="external">"Focal atrial tachycardia", section on 'Electrocardiographic features'</a>.)</p><p></p><p class="bulletIndent1">Algorithms have been developed to help the clinician estimate the anatomic source of the atrial tachycardia based on the P wave morphology, but these are derived mostly from adults [<a href="#rid50">50,51</a>].</p><p></p><p class="bulletIndent1">Automatic versus nonautomatic FAT cannot easily be distinguished based on surface ECG.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sinoatrial node reentry tachycardia (SANRT)</strong> – SANRT, which is a form of nonautomatic FAT, is a paroxysmal arrhythmia with P wave morphology identical to that during sinus rhythm and a longer PR interval than would be expected for exercise-induced sinus tachycardia at the same heart rate  (<a class="graphic graphic_waveform graphicRef131133 graphicRef131339" href="/z/d/graphic/131133.html" rel="external">waveform 2A-B</a>). As with other FATs, the P waves may even be partially superimposed on the previous T wave. (See  <a class="medical medical_review" href="/z/d/html/918.html" rel="external">"Sinoatrial nodal reentrant tachycardia (SANRT)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>CAT</strong> – The following ECG findings are required for the diagnosis of CAT  (<a class="graphic graphic_waveform graphicRef52317" href="/z/d/graphic/52317.html" rel="external">waveform 3</a>) [<a href="#rid52">52,53</a>] (see  <a class="medical medical_review" href="/z/d/html/901.html" rel="external">"Multifocal atrial tachycardia"</a>):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Discrete P waves with at least <strong>three</strong> different morphologies (including the normal sinus P wave) in any single lead. P wave morphology is generally best seen in leads II, III, and V1.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The P-P intervals, the P-R duration, and the R-R intervals vary.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Atrial rate &gt;100 bpm (usually 250 to 600 bpm).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The P waves are separated by isoelectric intervals, albeit brief, which discriminates this rhythm from atrial fibrillation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Atrial fibrillation</strong> – Atrial fibrillation is an irregular rhythm without regular or organized atrial activity  (<a class="graphic graphic_waveform graphicRef62698" href="/z/d/graphic/62698.html" rel="external">waveform 4</a>). Multiple reentrant circuits within the atrial myocardium generate multiple mobile wavelets, which often compete with or even extinguish each other. As a result, no uniform activation of the atrial tissue and no distinctive P waves are generated or recognized on the surface ECG. Since these multiple wavelets generate rapid and localized impulses, the sinus node is suppressed or not able to be expressed, as it cannot activate the atrium. (See  <a class="medical medical_review" href="/z/d/html/1014.html" rel="external">"The electrocardiogram in atrial fibrillation"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>IART</strong> – This arrhythmia usually has a 2:1 AV conduction relationship. The atrial rate is generally 260 to 320 bpm and results in a ventricular rate usually between 100 and 150 bpm  (<a class="graphic graphic_waveform graphicRef82303" href="/z/d/graphic/82303.html" rel="external">waveform 5A</a>). The flutter waves usually have a monotonously repeating saw tooth pattern due to a constantly undulating or zigzag baseline. This pattern either represents continuous depolarization and repolarization of the atria, or right followed by left atrial depolarization. (See  <a class="medical medical_review" href="/z/d/html/1061.html" rel="external">"Electrocardiographic and electrophysiologic features of atrial flutter"</a>.)</p><p></p><p class="bulletIndent1">In some cases in which 2:1 AV block makes it difficult to recognize atrial flutter, persistent flutter waves can be demonstrated by vagal maneuvers or the use of intravenous <a class="drug drug_pediatric" data-topicid="13258" href="/z/d/drug information/13258.html" rel="external">adenosine</a>  (<a class="graphic graphic_waveform graphicRef72312" href="/z/d/graphic/72312.html" rel="external">waveform 5B</a>).</p><p></p><p>The 12-lead ECG can also help to discriminate between sinus tachycardia due to decompensated dilated cardiomyopathy and tachycardia-induced cardiomyopathy caused by tachyarrhythmia emanating from a focus near the sinus node. Features that favor tachycardia-induced cardiomyopathy include absence of second-degree AV block or a negative P wave in both leads V1 and V2 [<a href="#rid54">54</a>].</p><p class="headingAnchor" id="H5913206"><span class="h1">APPROACH TO DIAGNOSIS</span></p><p class="headingAnchor" id="H3827459421"><span class="h2">Initial evaluation</span><span class="headingEndMark"> — </span>The general approach to diagnosing an AT in pediatric patients is as follows:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Electrocardiogram (ECG</strong>) – The first step in the evaluation is to obtain a 12-lead surface ECG. ECG findings for specific types of AT are described above (see <a class="local">'Electrocardiogram findings'</a> above). ECG findings in more common forms of supraventricular tachycardia (SVT; ie, atrioventricular [AV] reciprocating tachycardia and AV node reentrant tachycardia) are reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/5783.html" rel="external">"Clinical features and diagnosis of supraventricular tachycardia (SVT) in children", section on 'Electrocardiogram'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ambulatory monitoring</strong> – For patients with paroxysmal symptoms, the AT may not be present during routine ECG and ambulatory monitoring is required to make the diagnosis.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Monitoring with smart mobile devices</strong> – The burgeoning industry of smartphones and smartwatches has made home monitoring more available and less expensive than it was when traditional medical devices were all that were available. However, at least to date, the rhythm recordings from these devices are limited to a single lead (usually limb lead I or inverted I). In addition, they afford limited recording time, usually missing the onset or termination of an abnormal rhythm. While these limitations usually do not preclude identification of irregular atrial tachycardias (eg, atrial fibrillation) or common forms of SVT, these devices may be less reliable for identifying focal atrial tachycardia (FAT). This is because detecting FAT relies upon a combination of identifying non-sinus P waves and sudden onset or termination. Nevertheless, these devices may suggest an FAT if the PR interval is inappropriately long relative to the atrial rate.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Attached event recorders</strong> – Traditional ambulatory recording strategies still have a role when smart mobile devices are not helpful. These devices can be used for up to one month. They record extended rhythm strips associated with clinical tachycardic events that are either patient-triggered or based on preprogrammed criteria. They have been downsized and can be hidden beneath the child's shirt, making them more acceptable to young patients. The recording time of events enables documentation of event onset and/or termination, and more than one channel is available, so that comparison with the pre- or post-event sinus P wave can be made. Some devices will continuously record for up to two weeks. (See  <a class="medical medical_review" href="/z/d/html/958.html" rel="external">"Ambulatory ECG monitoring"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Insertable loop recorders</strong> – Children with very infrequent but very severe symptoms may benefit from placement of an insertable loop recorder. New generation devices are small and can be injected under the skin of the chest with a battery life of &gt;3 years. Clinical events can be recorded using an external activator or automatically according to programmed criteria. In addition to the very long surveillance period, its advantages over attached recorders include better quality signals, longer recording duration per event, and a better opportunity to record an event onset or termination [<a href="#rid55">55</a>]. Its ability to discriminate AT from sinus tachycardia is otherwise the same as an attached monitor because it only records a single ECG channel.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Exercise testing</strong> – For patients in whom symptoms primarily occur during exercise, formal exercise testing while being attached to a 12-lead ECG can establish the diagnosis, determine the hemodynamic effects, and even possibly localize the source of the tachycardia. Unfortunately, the yield of this testing is low. (See  <a class="medical medical_review" href="/z/d/html/6473.html" rel="external">"Exercise testing in children and adolescents: Principles and clinical application"</a>.)</p><p></p><p class="headingAnchor" id="H5913227"><span class="h2">Subsequent testing</span><span class="headingEndMark"> — </span>Once the diagnosis of an AT has been established, additional testing may include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Echocardiogram</strong> – Transthoracic echocardiography is used to assess myocardial function and to identify any structural cardiac defects that may have precipitated the rhythm disturbance, including congenital defects (ie, congenital heart disease [CHD]) or acquired lesions (ie, atrial tumors). Transesophageal echocardiography may be necessary in some patients as it provides better anatomic detail of the atrial appendages and is necessary to identify intracavitary clot. This is especially important in patients with CHD or cardiomyopathy associated with atrial flutter, atrial fibrillation, or intraatrial reentry tachycardia.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cardiac magnetic resonance imaging</strong> – Cardiac magnetic resonance imaging may be especially helpful to identify cardiac tumors and to evaluate the form and function of the atrial appendages. Newer techniques can identify regions of fibrosis, even in the thin-walled atria. (See  <a class="medical medical_review" href="/z/d/html/5314.html" rel="external">"Clinical utility of cardiovascular magnetic resonance imaging"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Electrophysiology study</strong> – An electrophysiology study is used to confirm the underlying arrhythmia, determine its mechanism, identify site(s) of origin (focus or foci), and guide therapeutic decisions (eg, ablation or change in antiarrhythmic drug therapy). Catheter ablation can be performed as a therapeutic intervention at the same time as the diagnostic electrophysiology study. (See <a class="local">'Chronic management'</a> below and  <a class="medical medical_review" href="/z/d/html/980.html" rel="external">"Invasive diagnostic cardiac electrophysiology studies"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation for channelopathy</strong> – For children diagnosed with ATs (particularly atrial fibrillation and atrial flutter) without an identified etiology, a heritable primary arrhythmia syndrome should be considered (eg, long and short QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia). While these syndromes are characteristically associated with increased risk of ventricular arrhythmias, up to 30 percent of affected patients experience ATs [<a href="#rid3">3</a>]. The initial step to evaluating for these syndromes is to obtain a detailed family history, including a three-generation pedigree. Additional details of the evaluation are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1053.html" rel="external">"Congenital long QT syndrome: Diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/16697.html" rel="external">"Short QT syndrome"</a> and  <a class="medical medical_review" href="/z/d/html/106759.html" rel="external">"Brugada syndrome: Clinical presentation, diagnosis, and evaluation"</a> and  <a class="medical medical_review" href="/z/d/html/916.html" rel="external">"Catecholaminergic polymorphic ventricular tachycardia"</a>.)</p><p></p><p class="headingAnchor" id="H5913234"><span class="h1">MANAGEMENT</span></p><p class="headingAnchor" id="H5913249"><span class="h2">Acute management</span><span class="headingEndMark"> — </span>The acute management of an infant or child who presents with narrow complex tachyarrhythmia is challenging because the exact mechanism of tachycardia is often unknown. The acute management is dependent on the patient's presentation and clinical status. The goal of therapy is to initially stabilize any patient with hemodynamic instability and to terminate the arrhythmia. Emergency management of narrow complex tachycardia is summarized in the algorithm  (<a class="graphic graphic_algorithm graphicRef129940" href="/z/d/graphic/129940.html" rel="external">algorithm 1</a>) and discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/6392.html" rel="external">"Pediatric advanced life support (PALS)", section on 'Tachycardia algorithm'</a>.)</p><p>Most children who present with acute onset of narrow complex tachyarrhythmia have a common form of supraventricular tachycardia (SVT; ie, atrioventricular [AV] reentrant tachycardia or AV nodal reentrant tachycardia). The acute management of SVT in children is summarized in the table  (<a class="graphic graphic_table graphicRef53559" href="/z/d/graphic/53559.html" rel="external">table 2</a>) and discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/5782.html" rel="external">"Management of supraventricular tachycardia (SVT) in children", section on 'Acute management'</a>.)</p><p>An important consideration in the acute management of ATs is that while cardioversion is effective for many forms of AT (including most forms of nonautomatic focal atrial tachycardia [FAT], atrial flutter, atrial fibrillation, and intraatrial reentry tachycardia), it is <strong>not</strong> effective for automatic FAT. For children with automatic FAT that is associated with signs of congestive heart failure and low cardiac output, the goal of acute management is the same as for any SVT (namely, rapid reduction of heart rate). However, since first-line interventions for SVT (<a class="drug drug_pediatric" data-topicid="13258" href="/z/d/drug information/13258.html" rel="external">adenosine</a>, electrical cardioversion) are generally ineffective for automatic FAT, other pharmacologic agents are usually necessary. Consultation with a pediatric cardiologist is advised. Traditional medications such as intravenous <a class="drug drug_pediatric" data-topicid="13279" href="/z/d/drug information/13279.html" rel="external">esmolol</a>, <a class="drug drug_pediatric" data-topicid="12732" href="/z/d/drug information/12732.html" rel="external">procainamide</a>, and <a class="drug drug_pediatric" data-topicid="12587" href="/z/d/drug information/12587.html" rel="external">amiodarone</a> are variably efficacious in this setting. However, intravenous amiodarone can cause cardiovascular collapse, particularly when given rapidly [<a href="#rid56">56</a>]. Thus, extreme caution should be used when administering amiodarone in this setting. Newer pharmacologic options include intravenous <a class="drug drug_pediatric" data-topicid="12802" href="/z/d/drug information/12802.html" rel="external">sotalol</a> [<a href="#rid57">57</a>] and enteral <a class="drug drug_pediatric" data-topicid="121652" href="/z/d/drug information/121652.html" rel="external">ivabradine</a> [<a href="#rid58">58,59</a>]; however, experience with these agents is limited. Anecdotal experience supports the use of <a class="drug drug_pediatric" data-topicid="13128" href="/z/d/drug information/13128.html" rel="external">dexmedetomidine</a> as a temporizing means of rate control until antiarrhythmic medications can be loaded. Intravenous <a class="drug drug_pediatric" data-topicid="13230" href="/z/d/drug information/13230.html" rel="external">digoxin</a> is generally not effective, though it may nominally lower heart rate. If a child's cardiovascular status is too tenuous to tolerate days of varying antiarrhythmic drug trials, support with extracorporeal membrane oxygenation may be required until the tachyarrhythmia is suppressed with medications or its focus (foci) can be ablated in the electrophysiology laboratory.</p><p class="headingAnchor" id="H5913256"><span class="h2">Chronic management</span><span class="headingEndMark"> — </span>After the acute episode is terminated, chronic management for AT is dependent upon the specific arrhythmia, age and size of the child, likelihood of spontaneous resolution, and severity of symptoms. In most cases, options include pharmacologic therapy and catheter ablation. The optimal approach is uncertain since there are few data to inform decision-making. Management varies from institution to institution. In general, treatment is chiefly pharmacologic for young/small patients (ie, &lt;15 kg) with catheter ablation reserved for patients in whom pharmacologic options have been exhausted [<a href="#rid60">60</a>]. This is because of size considerations and safety concerns of catheter ablation in small patients. By contrast, catheter ablation is used more often as a first-line treatment in older/larger children with atrial ATs [<a href="#rid60">60</a>].</p><p>The following sections outline our initial approach for more common pediatric scenarios based on the underlying specific arrhythmia, likelihood of resolution, response to medical therapy, and severity of symptoms.</p><p class="headingAnchor" id="H87931592"><span class="h3">Focal atrial tachycardia</span><span class="headingEndMark"> — </span>As noted above, the rate of spontaneous resolution of FAT is age dependent, and symptoms may vary from mild symptoms of episodic palpitations to sustained tachycardia with congestive heart failure from tachycardia-induced cardiomyopathy. (See <a class="local">'Focal atrial tachycardia'</a> above.)</p><p>Management of these arrhythmias is complicated by the fact that cardioversion is generally ineffective for automatic FAT because of its mechanism (enhanced automaticity). Patients presenting acutely with severe manifestations (eg, low cardiac output) generally require acute intervention to lower the heart rate, as discussed above (see <a class="local">'Acute management'</a> above). In children with less severe presentations and those who require ongoing therapy after the acute episode has been treated, the general approach to chronic management is as follows:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Infants and young children</strong> – In infants with tachycardia-induced cardiomyopathy, pharmacologic therapy is the initial approach because of the high likelihood of eventual spontaneous resolution. The optimal choice of medication for initial treatment and for resistant arrhythmias is uncertain [<a href="#rid25">25,61-66</a>]. Agents that are used for complete suppression of the tachyarrhythmia include oral beta blockers, <a class="drug drug_pediatric" data-topicid="12587" href="/z/d/drug information/12587.html" rel="external">amiodarone</a> [<a href="#rid25">25,67</a>], <a class="drug drug_general" data-topicid="9821" href="/z/d/drug information/9821.html" rel="external">propafenone</a> [<a href="#rid61">61-63</a>], <a class="drug drug_pediatric" data-topicid="13302" href="/z/d/drug information/13302.html" rel="external">flecainide</a> [<a href="#rid64">64,67</a>], <a class="drug drug_pediatric" data-topicid="12802" href="/z/d/drug information/12802.html" rel="external">sotalol</a> [<a href="#rid66">66</a>], and <a class="drug drug_pediatric" data-topicid="121652" href="/z/d/drug information/121652.html" rel="external">ivabradine</a> [<a href="#rid58">58</a>]. A combination of two drugs (eg, propafenone and amiodarone, sotalol and propafenone) may be required in some cases [<a href="#rid23">23,68</a>]. However, it should be stressed that patients should <strong>not</strong> be treated simultaneously with two drugs from the same class (eg, propafenone and flecainide). In patients with reduced ventricular function, flecainide, propafenone, and beta blockers should be avoided or used with caution.</p><p></p><p class="bulletIndent1">If the arrhythmia is suppressed, drug therapy is tolerated, and cardiac function normalizes, the drug is usually discontinued after one year since the arrhythmia is expected to resolve in most cases.</p><p></p><p class="bulletIndent1">For very young children with tachycardia-induced cardiomyopathy who fail drug therapy, an ablation procedure should be considered since the potential risks associated with ablation are likely to be low relative to the risks of progressive cardiomyopathy associated with the arrhythmia.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Older/larger children (≥15 kg)</strong> – In older children, if ventricular function is still preserved, medical management may be initiated with a beta blocker to lower the ventricular rate. However, in children weighing ≥15 kg, catheter ablation has become widely accepted as the treatment of choice rather than pharmacologic therapy due to the marginal safety profiles of antiarrhythmic drugs [<a href="#rid60">60</a>]. If there is evidence of tachycardia-induced cardiomyopathy, catheter ablation is generally performed as soon as the patient is considered sufficiently stable to undergo the procedure [<a href="#rid69">69</a>].</p><p></p><p class="bulletIndent1">Catheter ablation, usually using radiofrequency energy, is the primary therapy for automatic FAT in older children (ie, 15 ≥kg) and has been used to treat patients with AT with any the following:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Symptomatic tachyarrhythmia</p><p class="bulletIndent2"><span class="glyph">•</span>Tachycardia-induced cardiomyopathy</p><p class="bulletIndent2"><span class="glyph">•</span>Ineffective response to antiarrhythmic drugs</p><p class="bulletIndent2"><span class="glyph">•</span>Recurrence of tachycardia after drug discontinuation</p><p></p><p class="bulletIndent1">In a report of 376 foci of automatic FAT (as also called atrial ectopic tachycardia [AET]) from the Pediatric Radiofrequency Catheter Ablation Registry, ablation was initially successful in 88 percent of cases [<a href="#rid70">70</a>]. However, the recurrence rate following ablation for automatic FAT is probably higher than for other forms of SVT. This is because sedation for the procedure may suppress automatic foci so that tachycardias may be quiescent and thus not treatable. In another report of 36 patients, the initial success rate for ablation of FAT was 97 percent, with a recurrence rate of 20 percent [<a href="#rid71">71</a>]. Recurrences were more likely if there were multiple foci.</p><p></p><p class="bulletIndent1">Complications are uncommon. In the report from the Registry, complications occurred in 3 percent of cases, including stenosis of the superior cavoatrial junction, pulmonary vein ostial stenosis, phrenic nerve damage, and sinus node damage [<a href="#rid70">70</a>]. Complications are more likely to occur in small atria. Catheter ablation of foci near the AV node carries the risk of heart block; cryoablation techniques are preferred in that region due to a better safety profile.</p><p></p><p class="bulletIndent1">Catheter ablation is usually performed using transvenous access (typically via the femoral vein). However, in some cases, alternative approaches are preferred because of the location of the focus. An epicardial FAT focus can be especially challenging, and percutaneous pericardial access is performed in some centers. When FAT foci are in the atrial appendages, a minimally invasive surgical approach using thoracoscopy may be used [<a href="#rid72">72</a>].</p><p></p><p class="bulletIndent1">Catheter ablation is discussed in greater detail separately. (See  <a class="medical medical_review" href="/z/d/html/1007.html" rel="external">"Overview of catheter ablation of cardiac arrhythmias"</a>.)</p><p></p><p class="headingAnchor" id="H87931637"><span class="h3">Chaotic atrial tachycardia</span><span class="headingEndMark"> — </span>As noted above, pediatric chaotic atrial tachycardia (CAT) is most often seen as a transient condition in infants, with resolution in 50 percent within five months [<a href="#rid37">37</a>]. (See <a class="local">'Chaotic atrial tachycardia'</a> above.)</p><p>Medical treatment of CAT is challenging because typical maneuvers aimed at converting to sinus rhythm (eg, <a class="drug drug_pediatric" data-topicid="13258" href="/z/d/drug information/13258.html" rel="external">adenosine</a>, overdrive pacing, or synchronized cardioversion) are often not successful. As a result, therapy is directed at controlling the ventricular response rate with a combination of oral <a class="drug drug_pediatric" data-topicid="13230" href="/z/d/drug information/13230.html" rel="external">digoxin</a>, beta blockers, and calcium channel blockers. If this strategy is unsuccessful, and especially if tachycardia-induced cardiomyopathy is present, pharmacologic cardioversion is attempted with oral <a class="drug drug_pediatric" data-topicid="12587" href="/z/d/drug information/12587.html" rel="external">amiodarone</a> [<a href="#rid73">73</a>], <a class="drug drug_pediatric" data-topicid="13302" href="/z/d/drug information/13302.html" rel="external">flecainide</a> [<a href="#rid74">74</a>], or <a class="drug drug_general" data-topicid="9821" href="/z/d/drug information/9821.html" rel="external">propafenone</a> [<a href="#rid36">36,75</a>]. Once sinus rhythm is established and ventricular function normalizes, we usually continue therapy for an additional six months to a maximum of one year for responsive patients.</p><p>Patients are followed with ambulatory rhythm monitoring and echocardiography every month until ventricular function normalizes and then less frequently. It is reasonable to follow these patients periodically until school age.</p><p>Given the natural history of CAT in pediatric patients, catheter ablation usually does not play a role in management. However, successful use of catheter ablation in this setting has been described in single case reports [<a href="#rid32">32,33</a>]. This suggests that, in some cases, CAT may emanate from a single ectopic focus.</p><p class="headingAnchor" id="H87931664"><span class="h3">Neonatal atrial flutter</span><span class="headingEndMark"> — </span>In the newborn with atrial flutter, direct current cardioversion is the usual primary therapy [<a href="#rid76">76</a>]. An alternative to electrical cardioversion is the use of esophageal pacing at a cycle length 50 to 100 milliseconds less than that of the atrial rate, which is also used in children with atrial flutter or intraatrial reentrant tachycardia (IART) after cardiac surgery [<a href="#rid77">77</a>]. Beta blocker therapy or <a class="drug drug_pediatric" data-topicid="13230" href="/z/d/drug information/13230.html" rel="external">digoxin</a> are also reasonable options for initial therapy; however, most practitioners are moving away from using digoxin in this setting. Unlike older children and adults, intravenous calcium channel-blocking agents should be <strong>avoided</strong> in infants due to substantial risk of potentially fatal cardiovascular collapse. This same caveat also applies to intravenous beta blockers other than <a class="drug drug_pediatric" data-topicid="13279" href="/z/d/drug information/13279.html" rel="external">esmolol</a>. Once there is resolution of the arrhythmia, patients are followed for an additional 6 to 12 months with electrocardiogram (ECG) and ambulatory rhythm monitoring. Parents/caregivers are taught how to measure their infant's heart rate and how to recognize signs of early congestive heart failure. Wearable heart rate monitors designed for infants are in development and may be an option in the future. Recurrence is rare, and an evaluation for intrinsic structural, functional, or channelopathic conditions should be performed if there is a repeat event.</p><p>Support for this treatment approach comes from a case series of 50 infants with atrial flutter, of whom 13 (26 percent) had spontaneous conversion to sinus rhythm [<a href="#rid76">76</a>]. Of the remaining 37 infants, 22 underwent attempted transesophageal pacing, which was successful in 32 percent; 23 infants underwent direct current cardioversion, which was successful in 87 percent; and 7 patients (14 percent of the entire cohort) required antiarrhythmic therapy. Atrial flutter recurred in six infants (12 percent); five of the recurrences occurred within 24 hours of the first episode, and all of these patients had additional episodes of arrhythmia.</p><p class="headingAnchor" id="H5913271"><span class="h3">Other atrial tachyarrhythmias</span><span class="headingEndMark"> — </span>Management of ATs that occur mostly in patients who have undergone surgery for congenital heart disease (CHD; eg, atrial flutter, atrial fibrillation, or intraatrial reentry tachycardia) is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/13599.html" rel="external">"Atrial arrhythmias (including AV block) in congenital heart disease", section on 'Management'</a>.)</p><p class="headingAnchor" id="H826023807"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/116933.html" rel="external">"Society guideline links: Arrhythmias in children"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/116931.html" rel="external">"Society guideline links: Supraventricular arrhythmias"</a>.)</p><p class="headingAnchor" id="H5913278"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Terminology and classification</strong> – Atrial tachyarrhythmias (ATs) are non-sinus arrhythmias that result in a heart rate above the 95<sup>th</sup> percentile for age and that do not require the atrioventricular (AV) junction, accessory pathways, or ventricular tissue for initiation and maintenance of the elevated heart rate. ATs are classified based upon of P wave morphology on electrocardiogram (ECG), number of foci (single versus multiple), and the frequency and duration of tachycardia (ie, sporadic/paroxysmal versus persistent)  (<a class="graphic graphic_table graphicRef131338" href="/z/d/graphic/131338.html" rel="external">table 1</a>). (See <a class="local">'Terminology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology</strong> – ATs are commonly seen in children with congenital heart disease (CHD) who have undergone cardiac surgery; however, they also occur in children without cardiac surgery or CHD and can result in significant morbidity and mortality. Primary atrial tachycardias account for approximately 15 percent of pediatric supraventricular tachycardia (SVT). (See <a class="local">'Epidemiology'</a> above and  <a class="medical medical_review" href="/z/d/html/13599.html" rel="external">"Atrial arrhythmias (including AV block) in congenital heart disease"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Presentation</strong> – The signs and symptoms of ATs depend upon the duration and persistence of the tachycardia, ventricular response rate, and age of the patient (see <a class="local">'Presenting symptoms'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Paroxysmal tachycardia often presents with acute symptoms of palpitations, shortness of breath, presyncope, dizziness, fatigue, and sometimes chest pain. In the preverbal child, findings include irritability, pallor, diaphoresis, and feeding intolerance.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients with persistent tachyarrhythmia can develop tachycardia-induced cardiomyopathy, which may present with signs and symptoms of heart failure. Symptoms in infants may include poor feeding, sweating, failure to thrive, and tachypnea. Older children may present with dyspnea, fatigue on exertion, and diaphoresis.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Because infants and toddlers cannot verbally describe symptoms, they are more likely to present after a prolonged duration of arrhythmia with signs and symptoms of heart failure. Older children who can describe palpitations are generally detected earlier.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical features</strong> – The clinical features of specific ATs are summarized in the table  (<a class="graphic graphic_table graphicRef131338" href="/z/d/graphic/131338.html" rel="external">table 1</a>) and discussed above. (See <a class="local">'Clinical features of specific atrial tachyarrhythmias'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>ECG findings</strong> – The following are representative examples of ECG tracings for different types of AT. The ECG findings are discussed in greater detail above and in separate topic reviews. (See <a class="local">'Electrocardiogram findings'</a> above and  <a class="medical medical_review" href="/z/d/html/1014.html" rel="external">"The electrocardiogram in atrial fibrillation"</a> and  <a class="medical medical_review" href="/z/d/html/1061.html" rel="external">"Electrocardiographic and electrophysiologic features of atrial flutter"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Focal atrial tachycardia (FAT; also called atrial ectopic tachycardia [AET] or ectopic atrial tachycardia [EAT])  (<a class="graphic graphic_waveform graphicRef74611 graphicRef59685" href="/z/d/graphic/74611.html" rel="external">waveform 1A-B</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Sinoatrial node reentry tachycardia (SANRT)  (<a class="graphic graphic_waveform graphicRef131133 graphicRef131339" href="/z/d/graphic/131133.html" rel="external">waveform 2A-B</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Chaotic (or multifocal) atrial tachycardia (CAT)  (<a class="graphic graphic_waveform graphicRef52317" href="/z/d/graphic/52317.html" rel="external">waveform 3</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Atrial fibrillation  (<a class="graphic graphic_waveform graphicRef62698" href="/z/d/graphic/62698.html" rel="external">waveform 4</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Atrial flutter and intraatrial reentrant tachycardia (IART)  (<a class="graphic graphic_waveform graphicRef82303 graphicRef72312" href="/z/d/graphic/82303.html" rel="external">waveform 5A-B</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – The diagnostic evaluation begins with a 12-lead surface ECG. For patients with paroxysmal symptoms, the AT may not be present during routine ECG and ambulatory monitoring is required to make the diagnosis. For patients in whom symptoms occur primarily during exercise, formal exercise testing may help establish the diagnosis. (See <a class="local">'Approach to diagnosis'</a> above.)</p><p></p><p class="bulletIndent1">Following a presumptive diagnosis based on 12-lead ECG and/or ambulatory monitoring, additional cardiac testing may include echocardiography to assess cardiac function and anatomy as well as an electrophysiology study to confirm the underlying arrhythmia, determine its mechanism and site of origin, and to guide therapeutic decisions. (See <a class="local">'Subsequent testing'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Acute management</strong> – Emergency management of a child presenting with narrow complex tachycardia summarized in the algorithm  (<a class="graphic graphic_algorithm graphicRef129940" href="/z/d/graphic/129940.html" rel="external">algorithm 1</a>) and discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/6392.html" rel="external">"Pediatric advanced life support (PALS)", section on 'Tachycardia algorithm'</a>.)</p><p></p><p class="bulletIndent1">Most children who present with acute onset of narrow complex tachyarrhythmia have a common form of SVT. The acute management of SVT in children is summarized in the table  (<a class="graphic graphic_table graphicRef53559" href="/z/d/graphic/53559.html" rel="external">table 2</a>) and discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/5782.html" rel="external">"Management of supraventricular tachycardia (SVT) in children", section on 'Acute management'</a>.)</p><p></p><p class="bulletIndent1">An important consideration in the acute management of ATs is that while cardioversion is effective for many forms of AT (including most forms of nonautomatic FAT, atrial flutter, atrial fibrillation, and IART), it is <strong>not</strong> effective for automatic FAT. In extreme cases, cardiovascular support with extracorporeal membrane oxygenation may be necessary until automatic FAT can be suppressed with medications, or its focus (foci) can be ablated in the electrophysiology laboratory.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Chronic management</strong> – After the acute episode is terminated, chronic management is dependent upon the underlying arrhythmia, likelihood of resolution, severity of symptoms, and age/size of the child. The optimal approach is uncertain, and management varies from institution to institution. Treatment options generally include pharmacologic therapy and catheter ablation. (See <a class="local">'Chronic management'</a> above.)</p><p></p><p class="bulletIndent1">In general, because of safety concerns with the use of catheter ablation in infants and small children, pharmacologic therapy is more often used for this age group. By contrast, catheter ablation is often the first-line treatment in older/larger children with ATs. Our general approach is as follows:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>FAT</strong> – In <strong>infants</strong> with tachycardia-induced cardiomyopathy, pharmacologic therapy is the initial approach because of the high likelihood of eventual spontaneous resolution. A number of antiarrhythmic drugs have been used in this setting, and there is little evidence that any one agent is superior to another. For <strong>older children</strong> (ie, &gt;15 kg) with FAT, we suggest catheter ablation as the primary therapy (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). (See <a class="local">'Focal atrial tachycardia'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>CAT</strong> – Pediatric CAT is most often seen as a transient condition in infants, and it typically resolves within 6 to 12 months. For most patients, we suggest initial therapy to control the ventricular response rate (eg, with oral <a class="drug drug_pediatric" data-topicid="13230" href="/z/d/drug information/13230.html" rel="external">digoxin</a>, beta blocker, or calcium channel blocker) rather than antiarrhythmic therapy (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). However, if rate control is unsuccessful, it is reasonable to attempt pharmacologic cardioversion with an antiarrhythmic agent (eg, oral <a class="drug drug_pediatric" data-topicid="12587" href="/z/d/drug information/12587.html" rel="external">amiodarone</a>, <a class="drug drug_pediatric" data-topicid="13302" href="/z/d/drug information/13302.html" rel="external">flecainide</a>, or <a class="drug drug_general" data-topicid="9821" href="/z/d/drug information/9821.html" rel="external">propafenone</a>). Given the natural history of pediatric CAT, catheter ablation usually does not play a role in management, although successful catheter ablation has been described. (See <a class="local">'Chaotic atrial tachycardia'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Neonatal atrial flutter</strong> – For most neonates with atrial flutter, we suggest primary electrical cardioversion (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). However, overdrive esophageal pacing or medical therapy (eg, with a beta blocker or <a class="drug drug_pediatric" data-topicid="13230" href="/z/d/drug information/13230.html" rel="external">digoxin</a>) are reasonable alternatives. Intravenous calcium channel-blocking agents should be <strong>avoided</strong> in infants, due to substantial risk of potentially fatal cardiovascular collapse. (See <a class="local">'Neonatal atrial flutter'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Other ATs</strong> – Management of ATs that occur mostly in patients who have undergone surgery for CHD (eg, atrial flutter, atrial fibrillation, or IART) is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/13599.html" rel="external">"Atrial arrhythmias (including AV block) in congenital heart disease", section on 'Management'</a>.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Ko JK, Deal BJ, Strasburger JF, Benson DW Jr. Supraventricular tachycardia mechanisms and their age distribution in pediatric patients. Am J Cardiol 1992; 69:1028.</a></li><li><a class="nounderline abstract_t">Poutiainen AM, Koistinen MJ, Airaksinen KE, et al. Prevalence and natural course of ectopic atrial tachycardia. Eur Heart J 1999; 20:694.</a></li><li><a class="nounderline abstract_t">Conte G, Schotten U, Auricchio A. The Atrial Phenotype of the Inherited Primary Arrhythmia Syndromes. Arrhythm Electrophysiol Rev 2019; 8:42.</a></li><li><a class="nounderline abstract_t">Papagiannis J, Yang T, Glazer AM, et al. Incessant atrial and ventricular tachycardias associated with an SCN5A mutation. HeartRhythm Case Rep 2021; 7:806.</a></li><li><a class="nounderline abstract_t">Rajdev A, Groh WJ. Arrhythmias in the muscular dystrophies. Card Electrophysiol Clin 2015; 7:303.</a></li><li><a class="nounderline abstract_t">Villa CR, Czosek RJ, Ahmed H, et al. Ambulatory Monitoring and Arrhythmic Outcomes in Pediatric and Adolescent Patients With Duchenne Muscular Dystrophy. J Am Heart Assoc 2015; 5.</a></li><li><a class="nounderline abstract_t">Deitch AM, Giacone HM, Chubb H, et al. Arrhythmias in Williams Syndrome. Am J Cardiol 2023; 195:91.</a></li><li><a class="nounderline abstract_t">Quattrocelli A, Lang J, Davis A, Pflaumer A. Age makes a difference: Symptoms in pediatric supraventricular tachycardia. J Arrhythm 2018; 34:565.</a></li><li><a class="nounderline abstract_t">Moore JP, Patel PA, Shannon KM, et al. Predictors of myocardial recovery in pediatric tachycardia-induced cardiomyopathy. Heart Rhythm 2014; 11:1163.</a></li><li><a class="nounderline abstract_t">Fishberger SB, Colan SD, Saul JP, et al. Myocardial mechanics before and after ablation of chronic tachycardia. Pacing Clin Electrophysiol 1996; 19:42.</a></li><li><a class="nounderline abstract_t">Arslan A, Erdoğan İ, Varan B, et al. Reversible cardiomyopathy-tachycardiomyopathy in children. Turk J Pediatr 2019; 61:552.</a></li><li><a class="nounderline abstract_t">Tomita M, Ikeguchi S, Kagawa K, et al. Serial histopathologic myocardial findings in a patient with ectopic atrial tachycardia-induced cardiomyopathy. J Cardiol 1997; 29:37.</a></li><li><a class="nounderline abstract_t">Uniat J, Hill AC, Shwayder M, et al. Ectopic Atrial Tachycardia in Infants Following Congenital Heart Disease Surgery. Pediatr Cardiol 2023; 44:479.</a></li><li><a class="nounderline abstract_t">Wang JN, Wu JM, Tsai YC, Lin CS. Ectopic atrial tachycardia in children. J Formos Med Assoc 2000; 99:766.</a></li><li><a class="nounderline abstract_t">Donnerstein RL, Berg RA, Shehab Z, Ovadia M. Complex atrial tachycardias and respiratory syncytial virus infections in infants. J Pediatr 1994; 125:23.</a></li><li><a class="nounderline abstract_t">Wattenbarger LE, Kim JJ, Melicoff E, et al. Atrial tachyarrhythmias after lung transplantation in children: A common occurrence. Pediatr Transplant 2023; 27:e14410.</a></li><li><a class="nounderline abstract_t">Zhang Y, Li XM, Jiang H, et al. Right Atrial Appendage Aneurysm Resection to Cure Aneurysm-Related Atrial Tachyarrhythmia. Pediatr Cardiol 2019; 40:1144.</a></li><li><a class="nounderline abstract_t">Kanaya T, Nishigaki K, Yoshida Y, et al. Ectopic atrial tachycardia originating from right atrial appendage aneurysms in children: Three case reports. HeartRhythm Case Rep 2018; 4:2.</a></li><li><a class="nounderline abstract_t">Melo H, Moraes Neto F, Lapa C, Moraes CR. Congenital Aneurysm of the Right Atrium: Two Cases Report. Braz J Cardiovasc Surg 2019; 34:104.</a></li><li><a class="nounderline abstract_t">Di Pino A, Caruso E, Gitto P. The limbus of the fossa ovalis: an unusual location for incessant focal atrial tachycardia in children. Europace 2016; 18:1251.</a></li><li><a class="nounderline abstract_t">Tutar E, Çiftçi Ö, Fitoz S, et al. Lipomatous hypertrophy of the interatrial septum in a child with atrial tachycardia. Pediatr Int 2016; 58:523.</a></li><li><a class="nounderline abstract_t">Koca S, Topaloglu S, Cay S, Pac A. Electroanatomic mapping-guided radiofrequency ablation of adenosine sensitive incessant focal atrial tachycardia originating from the non-coronary aortic cusp in a child. Indian Pacing Electrophysiol J 2014; 14:258.</a></li><li><a class="nounderline abstract_t">Bauersfeld U, Gow RM, Hamilton RM, Izukawa T. Treatment of atrial ectopic tachycardia in infants &lt; 6 months old. Am Heart J 1995; 129:1145.</a></li><li><a class="nounderline abstract_t">Salerno JC, Kertesz NJ, Friedman RA, Fenrich AL Jr. Clinical course of atrial ectopic tachycardia is age-dependent: results and treatment in children &lt; 3 or &gt; or =3 years of age. J Am Coll Cardiol 2004; 43:438.</a></li><li><a class="nounderline abstract_t">Mehta AV, Sanchez GR, Sacks EJ, et al. Ectopic automatic atrial tachycardia in children: clinical characteristics, management and follow-up. J Am Coll Cardiol 1988; 11:379.</a></li><li><a class="nounderline abstract_t">Naheed ZJ, Strasburger JF, Benson DW Jr, Deal BJ. Natural history and management strategies of automatic atrial tachycardia in children. Am J Cardiol 1995; 75:405.</a></li><li><a class="nounderline abstract_t">Kang KT, Etheridge SP, Kantoch MJ, et al. Current management of focal atrial tachycardia in children: a multicenter experience. Circ Arrhythm Electrophysiol 2014; 7:664.</a></li><li><a class="nounderline abstract_t">Baek SM, Chung H, Song MK, et al. The Complexity of Pediatric Multifocal Atrial Tachycardia and Its Prognostic Factors. Korean Circ J 2018; 48:148.</a></li><li><a class="nounderline abstract_t">Choi N, Ko JM, Shin SH, et al. Phenotypic and Genetic Characteristics of Five Korean Patients with Costello Syndrome. Cytogenet Genome Res 2019; 158:184.</a></li><li class="breakAll">GeneReviews, Adam MP, Ardinger HH, Pagon RA, et al (Eds), University of Washington, Seattle 2020.</li><li><a class="nounderline abstract_t">Levin MD, Saitta SC, Gripp KW, et al. Nonreentrant atrial tachycardia occurs independently of hypertrophic cardiomyopathy in RASopathy patients. Am J Med Genet A 2018; 176:1711.</a></li><li><a class="nounderline abstract_t">Demir T, Ergül Y, Akdeniz C, Tuzcu V. Electroanatomic mapping-guided radiofrequency ablation of multifocal atrial tachycardia in a child. Anadolu Kardiyol Derg 2013; 13:391.</a></li><li><a class="nounderline abstract_t">Bevilacqua LM, Rhee EK, Epstein MR, Triedman JK. Focal ablation of chaotic atrial rhythm in an infant with cardiomyopathy. J Cardiovasc Electrophysiol 2000; 11:577.</a></li><li><a class="nounderline abstract_t">Farooki ZQ, Green EW. Multifocal atrial tachycardia in two neonates. Br Heart J 1977; 39:872.</a></li><li><a class="nounderline abstract_t">Salim MA, Case CL, Gillette PC. Chaotic atrial tachycardia in children. Am Heart J 1995; 129:831.</a></li><li><a class="nounderline abstract_t">Fish FA, Mehta AV, Johns JA. Characteristics and management of chaotic atrial tachycardia of infancy. Am J Cardiol 1996; 78:1052.</a></li><li><a class="nounderline abstract_t">Bradley DJ, Fischbach PS, Law IH, et al. The clinical course of multifocal atrial tachycardia in infants and children. J Am Coll Cardiol 2001; 38:401.</a></li><li><a class="nounderline abstract_t">Radford DJ, Izukawa T. Atrial fibrillation in children. Pediatrics 1977; 59:250.</a></li><li><a class="nounderline abstract_t">Kirsh JA, Walsh EP, Triedman JK. Prevalence of and risk factors for atrial fibrillation and intra-atrial reentrant tachycardia among patients with congenital heart disease. Am J Cardiol 2002; 90:338.</a></li><li><a class="nounderline abstract_t">Butters A, Isbister JC, Medi C, et al. Epidemiology and clinical characteristics of atrial fibrillation in patients with inherited heart diseases. J Cardiovasc Electrophysiol 2020; 31:465.</a></li><li><a class="nounderline abstract_t">El-Battrawy I, Roterberg G, Schlentrich K, et al. Clinical Profile and Long-Term Follow-Up of Children with Brugada Syndrome. Pediatr Cardiol 2020; 41:290.</a></li><li><a class="nounderline abstract_t">Ceresnak SR, Liberman L, Silver ES, et al. Lone atrial fibrillation in the young - perhaps not so "lone"? J Pediatr 2013; 162:827.</a></li><li><a class="nounderline abstract_t">El Assaad I, Hammond BH, Kost LD, et al. Management and outcomes of atrial fibrillation in 241 healthy children and young adults: Revisiting "lone" atrial fibrillation-A multi-institutional PACES collaborative study. Heart Rhythm 2021; 18:1815.</a></li><li><a class="nounderline abstract_t">Hayes CJ, Gersony WM. Arrhythmias after the Mustard operation for transposition of the great arteries: a long-term study. J Am Coll Cardiol 1986; 7:133.</a></li><li><a class="nounderline abstract_t">Gewillig M, Cullen S, Mertens B, et al. Risk factors for arrhythmia and death after Mustard operation for simple transposition of the great arteries. Circulation 1991; 84:III187.</a></li><li><a class="nounderline abstract_t">Garson A Jr, Bink-Boelkens M, Hesslein PS, et al. Atrial flutter in the young: a collaborative study of 380 cases. J Am Coll Cardiol 1985; 6:871.</a></li><li><a class="nounderline abstract_t">Flinn CJ, Wolff GS, Campbell RM, et al. Natural history of supraventricular rhythms in 182 children following the Mustard operation. J Am Coll Cardiol 1983; 1:613.</a></li><li><a class="nounderline abstract_t">Till J, Wren C. Atrial flutter in the fetus and young infant: an association with accessory connections. Br Heart J 1992; 67:80.</a></li><li><a class="nounderline abstract_t">Shah SS, Hellenbrand WE, Gallagher PG. Atrial flutter complicating neonatal Coxsackie B2 myocarditis. Pediatr Cardiol 1998; 19:185.</a></li><li><a class="nounderline abstract_t">Teh AW, Kistler PM, Kalman JM. Using the 12-lead ECG to localize the origin of ventricular and atrial tachycardias: part 1. Focal atrial tachycardia. J Cardiovasc Electrophysiol 2009; 20:706.</a></li><li><a class="nounderline abstract_t">Uhm JS, Shim J, Wi J, et al. An electrocardiography algorithm combined with clinical features could localize the origins of focal atrial tachycardias in adjacent structures. Europace 2014; 16:1061.</a></li><li><a class="nounderline abstract_t">Bisset GS 3rd, Seigel SF, Gaum WE, Kaplan S. Chaotic atrial tachycardia in childhood. Am Heart J 1981; 101:268.</a></li><li><a class="nounderline abstract_t">Liberthson RR, Colan SD. Multifocal or chaotic atrial rhythm: report of nine infants, delineation of clinical course and management, and review of the literature. Pediatr Cardiol 1982; 2:179.</a></li><li><a class="nounderline abstract_t">Gelb BD, Garson A Jr. Noninvasive discrimination of right atrial ectopic tachycardia from sinus tachycardia in "dilated cardiomyopathy". Am Heart J 1990; 120:886.</a></li><li><a class="nounderline abstract_t">Miller N, Roelle L, Lorimer D Jr, et al. A Single-center Experience Comparing First- Versus Second-generation Insertable Cardiac Monitors in Pediatric Patients. J Innov Card Rhythm Manag 2022; 13:5048.</a></li><li><a class="nounderline abstract_t">Saul JP, Scott WA, Brown S, et al. Intravenous amiodarone for incessant tachyarrhythmias in children: a randomized, double-blind, antiarrhythmic drug trial. Circulation 2005; 112:3470.</a></li><li><a class="nounderline abstract_t">Borquez AA, Aljohani OA, Williams MR, Perry JC. Intravenous Sotalol in the Young: Safe and Effective Treatment With Standardized Protocols. JACC Clin Electrophysiol 2020; 6:425.</a></li><li><a class="nounderline abstract_t">Janson CM, Tan RB, Iyer VR, et al. Ivabradine for treatment of tachyarrhythmias in children and young adults. HeartRhythm Case Rep 2019; 5:333.</a></li><li><a class="nounderline abstract_t">Xu X, Guo Y, Gao W, et al. Ivabradine monotherapy in pediatric patients with focal atrial tachycardia: a single-center study. Eur J Pediatr 2023; 182:2265.</a></li><li><a class="nounderline abstract_t">Philip Saul J, Kanter RJ, WRITING COMMITTEE, et al. PACES/HRS expert consensus statement on the use of catheter ablation in children and patients with congenital heart disease: Developed in partnership with the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American Academy of Pediatrics (AAP), the American Heart Association (AHA), and the Association for European Pediatric and Congenital Cardiology (AEPC). Heart Rhythm 2016; 13:e251.</a></li><li><a class="nounderline abstract_t">Heusch A, Kramer HH, Krogmann ON, et al. Clinical experience with propafenone for cardiac arrhythmias in the young. Eur Heart J 1994; 15:1050.</a></li><li><a class="nounderline abstract_t">Janousek J, Paul T. Safety of oral propafenone in the treatment of arrhythmias in infants and children (European retrospective multicenter study). Working Group on Pediatric Arrhythmias and Electrophysiology of the Association of European Pediatric Cardiologists. Am J Cardiol 1998; 81:1121.</a></li><li><a class="nounderline abstract_t">Celiker A, Ozer S, Ozme S, et al. Experience with propafenone for the treatment of cardiac arrhythmias in children. Turk J Pediatr 1990; 32:85.</a></li><li><a class="nounderline abstract_t">Perry JC, McQuinn RL, Smith RT Jr, et al. Flecainide acetate for resistant arrhythmias in the young: efficacy and pharmacokinetics. J Am Coll Cardiol 1989; 14:185.</a></li><li><a class="nounderline abstract_t">Evans VL, Garson A Jr, Smith RT, et al. Ethmozine (moricizine HCl): a promising drug for "automatic" atrial ectopic tachycardia. Am J Cardiol 1987; 60:83F.</a></li><li><a class="nounderline abstract_t">Maragnès P, Tipple M, Fournier A. Effectiveness of oral sotalol for treatment of pediatric arrhythmias. Am J Cardiol 1992; 69:751.</a></li><li><a class="nounderline abstract_t">Hill AC, Silka MJ, Bar-Cohen Y. A comparison of oral flecainide and amiodarone for the treatment of recurrent supraventricular tachycardia in children. Pacing Clin Electrophysiol 2019; 42:670.</a></li><li><a class="nounderline abstract_t">Ge H, Li X, Zhang Y, et al. [Clinical course and treatment of ectopic atrial tachycardia in 144 children]. Zhonghua Er Ke Za Zhi 2015; 53:214.</a></li><li><a class="nounderline abstract_t">Walsh EP, Saul JP, Hulse JE, et al. Transcatheter ablation of ectopic atrial tachycardia in young patients using radiofrequency current. Circulation 1992; 86:1138.</a></li><li><a class="nounderline abstract_t">Kugler JD, Danford DA, Houston KA, et al. Pediatric radiofrequency catheter ablation registry success, fluoroscopy time, and complication rate for supraventricular tachycardia: comparison of early and recent eras. J Cardiovasc Electrophysiol 2002; 13:336.</a></li><li><a class="nounderline abstract_t">Balla C, Foresti S, Ali H, et al. Long-term follow-up after radiofrequency ablation of ectopic atrial tachycardia in young patients. J Arrhythm 2019; 35:290.</a></li><li><a class="nounderline abstract_t">Torok RD, Wei B, Kanter RJ, et al. Thoracoscopic resection of the left atrial appendage after failed focal atrial tachycardia ablation. Ann Thorac Surg 2014; 97:1322.</a></li><li><a class="nounderline abstract_t">Celiker A, Koçak G, Lenk MK, et al. Short- and intermediate-term efficacy of amiodarone in infants and children with cardiac arrhythmia. Turk J Pediatr 1997; 39:219.</a></li><li><a class="nounderline abstract_t">Houyel L, Fournier A, Davignon A. Successful treatment of chaotic atrial tachycardia with oral flecainide. Int J Cardiol 1990; 27:27.</a></li><li><a class="nounderline abstract_t">Reimer A, Paul T, Kallfelz HC. Efficacy and safety of intravenous and oral propafenone in pediatric cardiac dysrhythmias. Am J Cardiol 1991; 68:741.</a></li><li><a class="nounderline abstract_t">Texter KM, Kertesz NJ, Friedman RA, Fenrich AL Jr. Atrial flutter in infants. J Am Coll Cardiol 2006; 48:1040.</a></li><li><a class="nounderline abstract_t">Butto F, Dunnigan A, Overholt ED, et al. Transesophageal study of recurrent atrial tachycardia after atrial baffle procedures for complete transposition of the great arteries. Am J Cardiol 1986; 57:1356.</a></li></ol></div><div id="topicVersionRevision">Topic 14407 Version 22.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1561973" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Supraventricular tachycardia mechanisms and their age distribution in pediatric patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10208790" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Prevalence and natural course of ectopic atrial tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30918666" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : The Atrial Phenotype of the Inherited Primary Arrhythmia Syndromes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34987964" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Incessant atrial and ventricular tachycardias associated with an SCN5A mutation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26002394" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Arrhythmias in the muscular dystrophies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26722125" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Ambulatory Monitoring and Arrhythmic Outcomes in Pediatric and Adolescent Patients With Duchenne Muscular Dystrophy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37037070" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Arrhythmias in Williams Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30327703" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Age makes a difference: Symptoms in pediatric supraventricular tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24751393" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Predictors of myocardial recovery in pediatric tachycardia-induced cardiomyopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8848376" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Myocardial mechanics before and after ablation of chronic tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31990473" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Reversible cardiomyopathy-tachycardiomyopathy in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9023678" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Serial histopathologic myocardial findings in a patient with ectopic atrial tachycardia-induced cardiomyopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36495348" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Ectopic Atrial Tachycardia in Infants Following Congenital Heart Disease Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11061071" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Ectopic atrial tachycardia in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8021780" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Complex atrial tachycardias and respiratory syncytial virus infections in infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36314299" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Atrial tachyarrhythmias after lung transplantation in children: A common occurrence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31152184" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Right Atrial Appendage Aneurysm Resection to Cure Aneurysm-Related Atrial Tachyarrhythmia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29379716" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Ectopic atrial tachycardia originating from right atrial appendage aneurysms in children: Three case reports.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30810683" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Congenital Aneurysm of the Right Atrium: Two Cases Report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27496952" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : The limbus of the fossa ovalis: an unusual location for incessant focal atrial tachycardia in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27322862" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Lipomatous hypertrophy of the interatrial septum in a child with atrial tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25408566" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Electroanatomic mapping-guided radiofrequency ablation of adenosine sensitive incessant focal atrial tachycardia originating from the non-coronary aortic cusp in a child.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7754946" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Treatment of atrial ectopic tachycardia in infants&lt;6 months old.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15013128" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Clinical course of atrial ectopic tachycardia is age-dependent: results and treatment in children&lt;3 or&gt;or =3 years of age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3339178" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Ectopic automatic atrial tachycardia in children: clinical characteristics, management and follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7856541" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Natural history and management strategies of automatic atrial tachycardia in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25015944" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Current management of focal atrial tachycardia in children: a multicenter experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29441747" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : The Complexity of Pediatric Multifocal Atrial Tachycardia and Its Prognostic Factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31394527" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Phenotypic and Genetic Characteristics of Five Korean Patients with Costello Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31394527" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Phenotypic and Genetic Characteristics of Five Korean Patients with Costello Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30055033" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Nonreentrant atrial tachycardia occurs independently of hypertrophic cardiomyopathy in RASopathy patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23618974" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Electroanatomic mapping-guided radiofrequency ablation of multifocal atrial tachycardia in a child.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10826938" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Focal ablation of chaotic atrial rhythm in an infant with cardiomyopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/901681" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Multifocal atrial tachycardia in two neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7900640" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Chaotic atrial tachycardia in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8916490" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Characteristics and management of chaotic atrial tachycardia of infancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11499730" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : The clinical course of multifocal atrial tachycardia in infants and children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/834508" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Atrial fibrillation in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12127629" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Prevalence of and risk factors for atrial fibrillation and intra-atrial reentrant tachycardia among patients with congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31930598" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Epidemiology and clinical characteristics of atrial fibrillation in patients with inherited heart diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31748893" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Clinical Profile and Long-Term Follow-Up of Children with Brugada Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23092527" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Lone atrial fibrillation in the young - perhaps not so "lone"?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34343691" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Management and outcomes of atrial fibrillation in 241 healthy children and young adults: Revisiting "lone" atrial fibrillation-A multi-institutional PACES collaborative study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3941200" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Arrhythmias after the Mustard operation for transposition of the great arteries: a long-term study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1934408" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Risk factors for arrhythmia and death after Mustard operation for simple transposition of the great arteries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4031302" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Atrial flutter in the young: a collaborative study of 380 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Natural history of supraventricular rhythms in 182 children following the Mustard operation</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1739532" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Atrial flutter in the fetus and young infant: an association with accessory connections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9565516" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Atrial flutter complicating neonatal Coxsackie B2 myocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19490271" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Using the 12-lead ECG to localize the origin of ventricular and atrial tachycardias: part 1. Focal atrial tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24381331" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : An electrocardiography algorithm combined with clinical features could localize the origins of focal atrial tachycardias in adjacent structures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7468435" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Chaotic atrial tachycardia in childhood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7111053" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Multifocal or chaotic atrial rhythm: report of nine infants, delineation of clinical course and management, and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2220542" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Noninvasive discrimination of right atrial ectopic tachycardia from sinus tachycardia in "dilated cardiomyopathy".</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35765585" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : A Single-center Experience Comparing First- Versus Second-generation Insertable Cardiac Monitors in Pediatric Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16316969" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Intravenous amiodarone for incessant tachyarrhythmias in children: a randomized, double-blind, antiarrhythmic drug trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32327076" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Intravenous Sotalol in the Young: Safe and Effective Treatment With Standardized Protocols.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31285993" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Ivabradine for treatment of tachyarrhythmias in children and young adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36869903" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Ivabradine monotherapy in pediatric patients with focal atrial tachycardia: a single-center study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26899545" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : PACES/HRS expert consensus statement on the use of catheter ablation in children and patients with congenital heart disease: Developed in partnership with the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American Academy of Pediatrics (AAP), the American Heart Association (AHA), and the Association for European Pediatric and Congenital Cardiology (AEPC).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7527342" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Clinical experience with propafenone for cardiac arrhythmias in the young.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9605053" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Safety of oral propafenone in the treatment of arrhythmias in infants and children (European retrospective multicenter study). Working Group on Pediatric Arrhythmias and Electrophysiology of the Association of European Pediatric Cardiologists.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2091375" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Experience with propafenone for the treatment of cardiac arrhythmias in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2500470" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Flecainide acetate for resistant arrhythmias in the young: efficacy and pharmacokinetics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3310591" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Ethmozine (moricizine HCl): a promising drug for "automatic" atrial ectopic tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1546649" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Effectiveness of oral sotalol for treatment of pediatric arrhythmias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30875081" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : A comparison of oral flecainide and amiodarone for the treatment of recurrent supraventricular tachycardia in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26165020" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : [Clinical course and treatment of ectopic atrial tachycardia in 144 children].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1394921" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Transcatheter ablation of ectopic atrial tachycardia in young patients using radiofrequency current.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12033349" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Pediatric radiofrequency catheter ablation registry success, fluoroscopy time, and complication rate for supraventricular tachycardia: comparison of early and recent eras.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31007796" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Long-term follow-up after radiofrequency ablation of ectopic atrial tachycardia in young patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24462413" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Thoracoscopic resection of the left atrial appendage after failed focal atrial tachycardia ablation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9223920" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Short- and intermediate-term efficacy of amiodarone in infants and children with cardiac arrhythmia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2110551" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Successful treatment of chaotic atrial tachycardia with oral flecainide.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1892080" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Efficacy and safety of intravenous and oral propafenone in pediatric cardiac dysrhythmias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16949499" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Atrial flutter in infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3717037" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Transesophageal study of recurrent atrial tachycardia after atrial baffle procedures for complete transposition of the great arteries.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
